Expression and function of the insulin receptor substrate proteins in cancer
about
Influence of miRNA in insulin signaling pathway and insulin resistance: micro-molecules with a major role in type-2 diabetesDiabetes and cancer: a consensus report.The Novel Functions of High-Molecular-Mass Complexes Containing Insulin Receptor Substrates in Mediation and Modulation of Insulin-Like Activities: Emerging Concept of Diverse Functions by IRS-Associated ProteinsOrder and disorder in large multi-site docking proteins of the Gab family--implications for signalling complex formation and inhibitor design strategiesIRS1 is highly expressed in localized breast tumors and regulates the sensitivity of breast cancer cells to chemotherapy, while IRS2 is highly expressed in invasive breast tumorsAssociation between Gastroenterological Malignancy and Diabetes Mellitus and Anti-Diabetic Therapy: A Nationwide, Population-Based Cohort StudyEarly beginnings - the emergence of complex signaling systems and cell-to-cell communicationThe small GTPase Rap1 promotes cell movement rather than stabilizes adhesion in epithelial cells responding to insulin-like growth factor I.Immunoprofiling of Adult-Derived Human Liver Stem/Progenitor Cells: Impact of Hepatogenic Differentiation and InflammationThe evolution of human cells in terms of protein innovation.Membrane localization of insulin receptor substrate-2 (IRS-2) is associated with decreased overall survival in breast cancerSelf-organization and regulation of intrinsically disordered proteins with folded N-termini.Exploring the evolutionary relationship of insulin receptor substrate family using computational biology.Insulin receptor substrate 2-mediated phosphatidylinositol 3-kinase signaling selectively inhibits glycogen synthase kinase 3β to regulate aerobic glycolysis.The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.Increased expression of IRS-1 is associated with lymph node metastasis in nasopharyngeal carcinoma.Altered gene expression patterns during the initiation and promotion stages of neonatally diethylstilbestrol-induced hyperplasia/dysplasia/neoplasia in the hamster uterus.c-Jun N-terminal Kinase 2 Regulates Multiple Receptor Tyrosine Kinase Pathways in Mouse Mammary Tumor Growth and Metastasis.The insulin receptor substrate (IRS) proteins: at the intersection of metabolism and cancer.Metabolic syndrome is associated with better prognosis in patients with tongue squamous cell carcinoma.A nonsynonymous polymorphism in IRS1 modifies risk of developing breast and ovarian cancers in BRCA1 and ovarian cancer in BRCA2 mutation carriers.Insulin receptor substrate-1 prevents autophagy-dependent cell death caused by oxidative stress in mouse NIH/3T3 cells.TGFβ/Smad3 regulates proliferation and apoptosis through IRS-1 inhibition in colon cancer cellsImbalance of angiogenesis in diabetic complications: the mechanisms.Relationship between Metabolic Syndrome and History of Cervical Cancer among a US National PopulationLooking at the carcinogenicity of human insulin analogues via the intrinsic disorder prism.Impact of diabetes mellitus on the survival of pancreatic cancer: a meta-analysis.IRS2 is a candidate driver oncogene on 13q34 in colorectal cancer.Conditional loss of ErbB3 delays mammary gland hyperplasia induced by mutant PIK3CA without affecting mammary tumor latency, gene expression, or signaling.IRS4 induces mammary tumorigenesis and confers resistance to HER2-targeted therapy through constitutive PI3K/AKT-pathway hyperactivationDocking proteins.Social context, stress, and plasticity of aging.Targeting the insulin-like growth factor 1 receptor (IGF1R) signaling pathway for cancer therapy.Beyond 'furballs' and 'dumpling soups' - towards a molecular architecture of signaling complexes and networks.What's in a loop?Diabetes mellitus: influences on cancer risk.Differential involvement of the microtubule cytoskeleton in insulin receptor substrate 1 (IRS-1) and IRS-2 signaling to AKT determines the response to microtubule disruption in breast carcinoma cells.Biomarkers Associated with Ischemic Stroke in Diabetes Mellitus Patients.miR-106a* inhibits the proliferation of renal carcinoma cells by targeting IRS-2.Growth of v-src-transformed cells in serum-free medium through the induction of growth factors.
P2860
Q26865641-61600B1E-8064-464D-AB0D-9B89B842928EQ27686977-43DC1D82-A762-426C-BF86-04A07C8ED595Q28088661-62037789-C800-4D1B-802D-6DC19ABCEA98Q28248627-B7C9B940-82E8-4D3A-B333-E4574D2D4E78Q28288521-EE5A2BD9-E9C2-46F3-9DFE-35426D521C4DQ28547270-085AC29D-9A7C-4D3B-801E-B2C62EF6DE65Q28750095-EB500B6E-EEC2-46FE-896F-72FE5206EE3BQ30009350-6ED2BB92-BD84-418E-A8D1-4BD3E63FC033Q33604750-04B71543-9628-4A1B-AF86-FF99AFC13D53Q33654324-EF778540-146C-4D2D-A8E0-25704DD8F031Q33801131-DECE5BB4-7528-4FCA-AE4B-7C29D3DD0BE8Q33828313-4CA88CAF-7294-47A4-BFE8-65979A50AFE0Q33833837-C2380A15-7DB8-4D11-B517-88AFDFCCFA24Q34073821-89B80FAF-3A57-4F73-9A72-E31F7C18929DQ34113485-6FD8654E-2936-444C-B6AC-15F2AB368CCBQ34371614-67B83EBB-5C20-42A6-8D85-C9877DAA49C8Q34664105-546648C0-03A0-4C68-8095-AEE04F24DDD7Q35034056-1F1FFFBA-75E5-4C9A-B674-C6797600A308Q35124588-3287D136-BC8D-4AE7-9936-8D9A4220C603Q36121181-0278B816-B6D6-4A90-A210-C89E6645F654Q36152991-41FD9496-5FD0-438D-A251-E7579E9464A3Q36198350-A7A614CC-96F6-417B-8BA1-31D2EA92D30CQ36348635-FC64C2A9-A6F0-4BCF-9FB9-BB31F36180D8Q36489031-29512410-F92A-4060-BDF0-076412236ABDQ36584268-228102CA-F9F3-4865-B674-1BF7B6118DDFQ36694319-1EC28D90-FE1F-4804-8C47-8A2F3F7C7BD8Q36733586-DE2C98DA-E1DA-403C-8EEF-400C3B082EBBQ36879136-6A2093AC-4D03-49AD-819A-92EF24B18C43Q36986301-749E02B6-60B5-43DA-BDE1-BBD1D0B17846Q37439397-4F7F9A60-A69E-4D67-9655-CE00679987C2Q37795116-86F7EF4A-EE3D-41AE-BA0E-224848CE3C2BQ37808759-8FBF94C8-E1EE-4D0C-9B76-05E73A007403Q37975246-B4D2712F-3442-4F78-963E-A9618205830DQ38019703-7E9CCA4B-AAB5-4385-A82A-329F08C1EACEQ38056547-04E4EC33-4E5C-47FF-9B49-85E598DBEABFQ38232006-0FB88921-9289-4825-BC77-67A9F4323E2EQ38711459-D532B0E3-C18C-4B2D-A882-30B91F64245EQ38853000-856ED13E-5691-4B74-AB45-81AB34EFF11BQ38870198-ED87720F-345D-42FF-A476-EB931B65C7D0Q39223458-03E332E0-C8C0-4223-B8ED-247F0BDB008E
P2860
Expression and function of the insulin receptor substrate proteins in cancer
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 17 June 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Expression and function of the insulin receptor substrate proteins in cancer
@en
Expression and function of the insulin receptor substrate proteins in cancer.
@nl
type
label
Expression and function of the insulin receptor substrate proteins in cancer
@en
Expression and function of the insulin receptor substrate proteins in cancer.
@nl
prefLabel
Expression and function of the insulin receptor substrate proteins in cancer
@en
Expression and function of the insulin receptor substrate proteins in cancer.
@nl
P2093
P2860
P356
P1476
Expression and function of the insulin receptor substrate proteins in cancer
@en
P2093
Katerina Mardilovich
Leslie M Shaw
Shannon L Pankratz
P2860
P2888
P356
10.1186/1478-811X-7-14
P577
2009-06-17T00:00:00Z
P5875
P6179
1016979671